 To date, the MMRC has opened through its clinical trials network 22 clinical trials with industry partners – including Novartis, Celgene, Merck, and Proteolix.MMRC clinical trials are also designed to include correlative studies to better understand what drugs are most effective in treating various sub-groups of patients with myeloma, laying the foundation for the development of personalized medicine.The MMRC Multiple Myeloma Genomics Initiative comprehensive genomic analysis program.